Bin Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bin Wang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Feng Ze
Department of Cardiac Electrophysiology Peking University People's Hospital Beijing China
2 shared publicationsXu Zhou
Department of Cardiology the First Affiliated Hospital of Shantou University Medical College Shantou Guangdong China
2 shared publicationsDing Li
Department of Cardiac Electrophysiology Peking University People's Hospital Beijing China
1 shared publicationXuebin Li
Department of Cardiac Electrophysiology Peking University People's Hospital Beijing China
1 shared publication- Xuebin Li
Peking University People’s Hospital, Beijing, China
1 shared publication
Latest Publications
- 6 September 2021
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 32 (11) , 3051-3056
Outcomes of temporary pacing using active fixation leads and externalized permanent pacemakers in patients with cardiovascular implantable electronic device infection and pacemaker dependency
Introduction: The incidence of cardiac implantable electronic device (CIED) infections is increasing. Complete device and lead removal are recommended for all patients with definite CIED system infection. In patients with pacemaker dependency, temporary pacing before reimplantation is necessary. In this study, temporary pacing using active fixation leads (TPAFL) was evaluated.Methods: We reviewed data from consecutive patients implanted with TPAFL after transvenous lead extraction at our center between November 2014 and October 2020.Results: TPAFL were placed in 334 patients. The mean age was 64.5 ± 16.4 years and 76.3% were males. Two hundred and forty (72%) were treated due to local pocket infection and 94 (28%) systemic infection. The indication for temporary pacing was sick sinus syndrome in 135 (40.4%) patients and complete or high‐grade atrioventricular (AV) block in 199 (59.6%) patients. The most common access site for lead implantation was the ipsilateral subclavian or axillary vein (78.9%). A new permanent CIED was reimplanted at 10.3 ± 9.2 days (median 10, range: 2–70) after implantation of the temporary pacing. There were five (1.5%) adverse events related to the temporary pacing during hospitalization. The median follow‐up duration was 23.1 months (interquartile range [IQR], 7.2–43.4 months). Only one patient (0.3%) developed recurrent CIED infection.Conclusion: TPAFL is safe and effective in pacemaker‐dependent patients after infected CIED removal. The rate of temporary pacing‐related complications, including lead dislodgment and reinfection of CIED is relatively low.
- 6 September 2021
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 32 (11) , 3051-3056
Outcomes of temporary pacing using active fixation leads and externalized permanent pacemakers in patients with cardiovascular implantable electronic device infection and pacemaker dependency
Introduction: The incidence of cardiac implantable electronic device (CIED) infections is increasing. Complete device and lead removal are recommended for all patients with definite CIED system infection. In patients with pacemaker dependency, temporary pacing before reimplantation is necessary. In this study, temporary pacing using active fixation leads (TPAFL) was evaluated.Methods: We reviewed data from consecutive patients implanted with TPAFL after transvenous lead extraction at our center between November 2014 and October 2020.Results: TPAFL were placed in 334 patients. The mean age was 64.5 ± 16.4 years and 76.3% were males. Two hundred and forty (72%) were treated due to local pocket infection and 94 (28%) systemic infection. The indication for temporary pacing was sick sinus syndrome in 135 (40.4%) patients and complete or high‐grade atrioventricular (AV) block in 199 (59.6%) patients. The most common access site for lead implantation was the ipsilateral subclavian or axillary vein (78.9%). A new permanent CIED was reimplanted at 10.3 ± 9.2 days (median 10, range: 2–70) after implantation of the temporary pacing. There were five (1.5%) adverse events related to the temporary pacing during hospitalization. The median follow‐up duration was 23.1 months (interquartile range [IQR], 7.2–43.4 months). Only one patient (0.3%) developed recurrent CIED infection.Conclusion: TPAFL is safe and effective in pacemaker‐dependent patients after infected CIED removal. The rate of temporary pacing‐related complications, including lead dislodgment and reinfection of CIED is relatively low.
- Open Access
- 17 June 2021
- Published by Wiley in Clinical Cardiology
- Vol. 44 (7) , 971-977
Efficacy and safety of transvenous lead extraction in the Chinese octogenarian patients
Background: Managing elderly patients with infection or malfunction deriving from a cardiac implantable electronic device (CIED) may be challenging. We report the safety and effectiveness of transvenous lead extraction in Chinese octogenarian patients.Hypothesis: Transvenous lead extraction can be performed safely and successfully in the Chinese octogenarians.Methods: We retrospectively identified all patients who underwent TLE at our institution between March 2013 and January 2021. This population was divided into the following two groups based solely on age: octogenarians and non‐octogenarians. These two groups were compared on the basis of several characteristics and clinical outcomes.Results: Consecutive 1106 patients were analyzed, including 184 (16.6%) octogenarians and 922(83.4%) non‐octogenarians. The octogenarians presented more comorbidities. A total of 378 leads and 2004 leads were removed from the patients in the octogenarian group and non‐octogenarian group, respectively. The mean lead implant duration was 6.1 ± 5.1 and 5.8 ± 4.6 years for octogenarians and non‐octogenarians (p = 0.296). The majority of the patients in both groups underwent TLE through the femoral approach (67.5% vs 61.6%, p = 0.14). The complete procedure success rate was similar between the octogenarian and non‐octogenarian group (96.7% vs.95.3%, p = 0.39). There were no differences with respect to the proportion of minor, major complications and deaths. Long‐term mortality (median time 3.3 years) after TLE in octogenarians was significantly higher compared with younger individuals.Conclusions: At experienced centers, transvenous lead extraction can be performed safely in Chinese octogenarians with procedural success rate and complication rate comparable to younger individuals.
- 17 June 2021
- Published by Wiley in Clinical Cardiology
- Vol. 44 (7) , 971-977
Open AccessEfficacy and safety of transvenous lead extraction in the Chinese octogenarian patients
Background: Managing elderly patients with infection or malfunction deriving from a cardiac implantable electronic device (CIED) may be challenging. We report the safety and effectiveness of transvenous lead extraction in Chinese octogenarian patients.Hypothesis: Transvenous lead extraction can be performed safely and successfully in the Chinese octogenarians.Methods: We retrospectively identified all patients who underwent TLE at our institution between March 2013 and January 2021. This population was divided into the following two groups based solely on age: octogenarians and non‐octogenarians. These two groups were compared on the basis of several characteristics and clinical outcomes.Results: Consecutive 1106 patients were analyzed, including 184 (16.6%) octogenarians and 922(83.4%) non‐octogenarians. The octogenarians presented more comorbidities. A total of 378 leads and 2004 leads were removed from the patients in the octogenarian group and non‐octogenarian group, respectively. The mean lead implant duration was 6.1 ± 5.1 and 5.8 ± 4.6 years for octogenarians and non‐octogenarians (p = 0.296). The majority of the patients in both groups underwent TLE through the femoral approach (67.5% vs 61.6%, p = 0.14). The complete procedure success rate was similar between the octogenarian and non‐octogenarian group (96.7% vs.95.3%, p = 0.39). There were no differences with respect to the proportion of minor, major complications and deaths. Long‐term mortality (median time 3.3 years) after TLE in octogenarians was significantly higher compared with younger individuals.Conclusions: At experienced centers, transvenous lead extraction can be performed safely in Chinese octogenarians with procedural success rate and complication rate comparable to younger individuals.